Literature DB >> 5408805

Virus-like particles in phytohemagglutinin-stimulated lymphocyte cultures with reference to bovine lymphosarcoma.

J M Miller, L D Miller, C Olson, K G Gillette.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5408805

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  60 in total

1.  Evaluation of a serum ELISA for detection of bovine leukemia viral antibodies in milk samples.

Authors:  James F Evermann; David M DeAvila; Steven M Parish; Catherine H Merritt; Katherine C Noble; Sampath Srikanth; Amanda L E Bronowski
Journal:  J Vet Diagn Invest       Date:  2019-06-24       Impact factor: 1.279

2.  Detection of proviral DNA in horse cells infected with equine infectious anemia virus.

Authors:  N R Rice; S Simek; O A Ryder; L Coggins
Journal:  J Virol       Date:  1978-06       Impact factor: 5.103

3.  Inhibition of bovine leukemia virus release by antiviral antibodies.

Authors:  D M Driscoll; M Onuma; C Olson
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

4.  Direct syncytial assay for the quantitation of bovine leukemia virus.

Authors:  C V Benton; A E Soria; R V Gilden
Journal:  Infect Immun       Date:  1978-04       Impact factor: 3.441

5.  The bovine leukosis virus.

Authors:  M Mussgay; B Dietzschold; B Frenzel; O R Kaaden; O C Straub; F Weiland
Journal:  Med Microbiol Immunol       Date:  1977       Impact factor: 3.402

6.  The pX region of the bovine leukemia virus is transcribed as a 2.1-kilobase mRNA.

Authors:  R Z Mamoun; T Astier-Gin; R Kettmann; J Deschamps; N Rebeyrotte; B J Guillemain
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

7.  Persistent infection of rabbits with bovine leukemia virus associated with development of immune dysfunction.

Authors:  C R Wyatt; D Wingett; J S White; C D Buck; D Knowles; R Reeves; N S Magnuson
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

8.  Protection of sheep against bovine leukemia virus (BLV) infection by vaccination with recombinant vaccinia viruses expressing BLV envelope glycoproteins: correlation of protection with CD4 T-cell response to gp51 peptide 51-70.

Authors:  M H Gatei; H M Naif; S Kumar; D B Boyle; R C Daniel; M F Good; M F Lavin
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

9.  The prevalence of proviral bovine leukemia virus in peripheral blood mononuclear cells at two subclinical stages of infection.

Authors:  M L Mirsky; C A Olmstead; Y Da; H A Lewin
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

10.  T-cell lines established from human T-lymphocytic neoplasias by direct response to T-cell growth factor.

Authors:  B J Poiesz; F W Ruscetti; J W Mier; A M Woods; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.